Antiviral therapy in chronic hepatitis E: A systematic review

Journal of Viral Hepatitis

Volumn 22, Issue 12, 2015, Pages 965-973

  Peters Van Ton, A M ^a   Gevers, T J G ^a   Drenth, J P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

chronic hepatitis E; pegylated interferon; ribavirin; treatment

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ERYTHROPOIETIN; ETANERCEPT; EVEROLIMUS; METHOTREXATE; MYCOPHENOLATE MOFETIL; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RAPAMYCIN; RIBAVIRIN; RITUXIMAB; STEROID; TACROLIMUS; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; RECOMBINANT PROTEIN; VIRUS RNA;

ALLOTRANSPLANTATION; ANEMIA; ATRIAL FIBRILLATION; CHRONIC HEPATITIS; CHRONIC HEPATITIS E; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY GRAFT REJECTION; LEUKOPENIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT RESPONSE; VIRAL CLEARANCE; ADULT; ADVERSE EFFECTS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; GENETICS; GRAFT REJECTION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; FEMALE; GRAFT REJECTION; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 84945460286     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12403     Document Type: Review

References (40)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al,. Hepatitis E. Lancet 2012; 379 (9835): 2477-2488.
2. Fujiwara S, Yokokawa Y, Morino K, Hayasaka K, Kawabata M, Shimizu T,. Chronic hepatitis E: a review of the literature. J Viral Hepat 2014; 21 (2): 78-89.
3. Hoofnagle JH, Nelson KE, Purcell RH,. Hepatitis E. N Engl J Med 2012; 367 (13): 1237-1244.
4. Suneetha PV, Pischke S, Schlaphoff V, et al,. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55 (3): 695-708.
5. Kamar N, Rostaing L, Abravanel F, et al,. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010; 139 (5): 1612-1618.
6. Kamar N, Abravanel F, Selves J, et al,. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89 (3): 353-360.
7. Kamar N, Izopet J, Tripon S, et al,. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014; 370 (12): 1111-1120.
8. Pischke S, Hardtke S, Bode U, et al,. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013; 33 (5): 722-726.
9. Koning L, Pas SD, de Man RA, et al,. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 2013; 32 (1): 78-85.
10. Neukam K, Barreiro P, Macias J, et al,. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013; 57 (3): 465-468.
11. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HGM,. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; 16 (4): 474-477.
12. Kamar N, Rostaing L, Abravanel F, et al,. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50 (5): e30-e33.
13. Fabrizi F, Lunghi G, Dixit V, Martin P,. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther 2006; 24 (10): 1413-1422.
14. Kamar N, Bismuth M, Hillaire S, Rostaing L, Mallet V,. Ribavirin is highly efficient at treating chronic hepatitis-E-virus infection in organ-transplant-patients: a Retrospective Multicenter French Study. Am J Transplant 2013; 13: 214-215.
15. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 2014; 60 (2): 392-420.
16. Alric L, Bonnet D, Palacin A, et al,. Comparison of virological response between ribavirin and peg-interferon monotherapy during autochtonous chronic hepatitis E virus infection. J Hepatol 2013; 58: S499.
17. Brok J, Gluud LL, Gluud C,. Ribavirin monotherapy for chronic hepatitis C. Cochrane Database Syst Rev 2009; 4: CD005527.
18. Veldt BJ, Brouwer JT, Adler M, et al,. Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]. BMC Gastroenterol 2003; 3: 24.
19. Kamar N, Garrouste C, Haagsma EB, et al,. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140 (5): 1481-1489.
20. Moal V, Legris T, Burtey S, et al,. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 2013; 85 (3): 462-471.
21. Li ZZ, Xue J, Chen LZ,. Primary risk factors of hepatitis E virus infection: a meta-analysis. Zhonghua Yu Fang Yi Xue Za Zhi 2013; 47 (12): 1148-1151.
22. Echevarria JM, Fogeda M, Avellon A,. [Epidemiology of hepatitis E virus infection in Spain.]. Enferm Infecc Microbiol Clin 2014; pii: S0213-005X(13)00389-3.
23. Hiroz P, Gouttenoire J, Dao Thi VL, et al,. [An update on hepatitis E]. Rev Med Suisse 2013; 9 (396): 1594.
24. Pischke S, Greer M, Hardtke S, et al,. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transpl Infect Dis 2014; 16 (2): 333-339.
25. Pischke S, Stiefel P, Franz B, et al,. Chronic hepatitis e in heart transplant recipients. Am J Transplant 2012; 12 (11): 3128-3133.
26. Riezebos-Brilman A, Puchhammer-Stockl E, van der Weide HY, et al,. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 2013; 32 (3): 341-346.
27. Mallet V, Nicand E, Sultanik P, et al,. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153 (2): 85-89.
28. Im GY, Sehgal V, Ward SC,. A case of undulating fevers and elevated liver tests after pancreas-kidney transplantation. Semin Liver Dis 2013; 33 (1): 89-93.
29. de Niet A, Zaaijer HL, ten Berge I, Weegink CJ, Reesink HW, Beuers U,. Chronic hepatitis E after solid organ transplantation. Neth J Med 2012; 70 (6): 261-266.
30. Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A,. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011; 30 (7): 841-843.
31. Klein F, Neuhaus R, Hofmann J, Rudolph B, Neuhaus P, Bahra M,. Successful treatment of chronic hepatitis E after an orthotopic liver transplant with ribavirin monotherapy. Exp Clin Transplant 2014; [E-pub ahead of print].
32. Taton B, Moreau K, Lepreux S, et al,. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transpl Infect Dis 2013; 15 (6): E211-E215.
33. Hajji H, Gerolami R, Solas C, Moreau J, Colson P,. Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. Int J Antimicrob Agents 2013; 41 (6): 595-597.
34. Roux CH, Anty R, Patouraux S, Euller-Ziegler L,. Hepatitis E: are rheumatic patients at risk? J Rheumatol 2013; 40 (1): 99.
35. Giordani MT, Fabris P, Brunetti E, Goblirsch S, Romano L,. Hepatitis E and lymphocytic leukemia in man, Italy. Emerg Infect Dis 2013; 19 (12): 2054-2056.
36. Alric L, Bonnet D, Beynes-Rauzy O, Izopet J, Kamar N,. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011; 106 (8): 1562-1563.
37. Ambrosioni J, Mamin A, Hadengue A, et al,. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin. Clin Microbiol Infect 2014; 20 (10): O718-20.
38. Alric L, Bonnet D, Laurent G, Kamar N, Izopet J,. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010; 153 (2): 135-136.
39. Jagjit Singh GK, Ijaz S, Rockwood N, et al,. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect 2013; 66 (1): 103-106.
40. Kamar N, Abravanel F, Garrouste C, et al,. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 2010; 25 (8): 2792-2795.